GENEVA, July 2 -- INTERVACC AB filed a patent application (EP2025/087962) for “IMPROVED IELISA FOR STRANGLES”. With publication no. WO/2026/132211, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: G01N 33/569
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....